Corbus Pharmaceuticals Holdings (CRBP) Net Shares Issued and Repurchased (2013 - 2025)

Corbus Pharmaceuticals Holdings has reported Net Shares Issued and Repurchased for 13 years, with the latest figure at $597375.0 in Q1 2025.

• On a quarterly basis, Net Shares Issued and Repurchased rose 198.51% year-over-year to $597375.0 in Q1 2025; TTM through Mar 2025 was $597375.0, a 198.51% increase from a year earlier, with the FY2024 full-year figure at $251041.0, down 13.78% from the prior year.
• Net Shares Issued and Repurchased was $597375.0 for Q1 2025 at Corbus Pharmaceuticals Holdings, up from $251041.0 in the prior quarter.
• The five-year high for Net Shares Issued and Repurchased was $6.0 million in Q1 2021, with the low at $185169.0 in Q4 2022.
• Average Net Shares Issued and Repurchased over 5 years is $1.4 million, with a median of $251041.0 recorded in 2024.
• The sharpest annual moves came in 2023 and 2025: Net Shares Issued and Repurchased plunged 94.67% in 2023, then soared 198.51% in 2025.
• Over 5 years, Net Shares Issued and Repurchased stood at $245793.0 in 2021, then declined by 24.66% to $185169.0 in 2022, then surged by 57.24% to $291151.0 in 2023, then dropped by 13.78% to $251041.0 in 2024, then soared by 137.96% to $597375.0 in 2025.
• The last three Net Shares Issued and Repurchased figures came in at $597375.0 (Q1 2025), $251041.0 (Q4 2024), and $200119.0 (Q1 2024), per Business Quant data.